Antibody Responses to SARS-CoV-2 Infection—Comparative Determination of Seroprevalence in Two High-Throughput Assays versus a Sensitive Spike Protein ELISA

Código QR

Antibody Responses to SARS-CoV-2 Infection—Comparative Determination of Seroprevalence in Two High-Throughput Assays versus a Sensitive Spike Protein ELISA

Robust assay development for SARS-CoV-2 serological testing requires assessment of asymptomatic and non-hospitalised individuals to determine if assays are sensitive to mild antibody responses. Our study evaluated the performance characteristics of two high-throughput SARS-CoV-2 IgG nucleocapsid ass...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dinesh Mohanraj, Kelly Bicknell, Malini Bhole, Caroline Webber, Lorna Taylor, Alison Whitelegg
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	SARS-CoV-2 Roche Elecsys SARS-CoV-2 antibody assay Abbott IgG antibody assay The Binding Site total antibody assay Medicine R
Acceso en línea:	https://doaj.org/article/cbf08496ca4240828788bffd618ed282
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Durability of Antibody Responses to SARS-CoV-2 Infection and Its Relationship to Disease Severity Assessed Using a Commercially Available Assay
por: Alanoud Alshami, et al.
Publicado: (2021)

Effective Prophylaxis of COVID-19 in Rhesus Macaques Using a Combination of Two Parenterally-Administered SARS-CoV-2 Neutralizing Antibodies
por: Brandon J. Beddingfield, et al.
Publicado: (2021)

Assessment of COVID-19 Incidence and the Ability to Synthesise Anti-SARS-CoV-2 Antibodies of Paediatric Patients with Primary Immunodeficiency
por: Karolina Pieniawska-Śmiech, et al.
Publicado: (2021)

SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
por: Doris Urlaub, et al.
Publicado: (2021)

Robust SARS-CoV-2 Antibody Responses in Asian COVID-Naïve Subjects 180 Days after Two Doses of BNT162b2 mRNA COVID-19 Vaccine
por: Chin-Shern Lau, et al.
Publicado: (2021)

S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit
por: Phuong Nguyen-Contant, et al.
Publicado: (2020)

Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2
por: Gururaj Rao Deshpande, et al.
Publicado: (2021)

Development of an Enzyme-Linked Immunosorbent Assay (ELISA) for Accurate and Prompt Coronavirus Disease 2019 (COVID-19) Diagnosis Using the Rational Selection of Serological Biomarkers
por: Theano Lagousi, et al.
Publicado: (2021)

Seroprevalence of Antibodies to SARS-CoV-2 in Guangdong Province, China between March to June 2020
por: Cheng Xiao, et al.
Publicado: (2021)

Evolution of SARS-CoV-2-Neutralizing Antibodies after Two Standard Dose Vaccinations, Risk Factors for Non-Response and Effect of a Third Dose Booster Vaccination in Non-Responders on Hemodialysis: A Prospective Multi-Centre Cohort Study
por: Frank-Peter Tillmann, et al.
Publicado: (2021)

SARS-CoV-2 Seroprevalence among a Southern U.S. Population Indicates Limited Asymptomatic Spread under Physical Distancing Measures
por: Amir Barzin, et al.
Publicado: (2020)

Antibody conversion rates to SARS-CoV-2 in saliva from children attending summer schools in Barcelona, Spain
por: Carlota Dobaño, et al.
Publicado: (2021)

Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect <italic toggle="yes">In Vivo</italic> in a Mouse Model in a Neutralization-Dependent Manner
por: Fatima Amanat, et al.
Publicado: (2021)

Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19
por: Helena Codina, et al.
Publicado: (2021)

Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects
por: Constant Gillot, et al.
Publicado: (2021)

Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques
por: Kim J. Hasenkrug, et al.
Publicado: (2021)

A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture
por: Christian Shema Mugisha, et al.
Publicado: (2020)

PDZ-Containing Proteins Targeted by the ACE2 Receptor
por: Célia Caillet-Saguy, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 Infection in the Colombo Municipality Region, Sri Lanka
por: Chandima Jeewandara, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark
por: Sebastian von Huth, et al.
Publicado: (2021)

Comparing Humoral and Cellular Adaptive Immunity during Convalescent Phase of COVID-19 in Hemodialysis Patients and Kidney Transplant Recipients
por: Dorota Kamińska, et al.
Publicado: (2021)

Investigating Adherence to COVID-19 Vaccination and Serum Antibody Concentration among Hospital Workers—The Experience of an Italian Private Hospital
por: Guglielmo Forgeschi, et al.
Publicado: (2021)

High Individual Heterogeneity of Neutralizing Activities against the Original Strain and Nine Different Variants of SARS-CoV-2
por: Rita Jaafar, et al.
Publicado: (2021)

IgG Study of Blood Sera of Patients with COVID-19
por: Elena Kazachinskaia, et al.
Publicado: (2021)

Studies on Growth Characteristics and Cross-Neutralization of Wild-Type and Delta SARS-CoV-2 From Hisar (India)
por: Nitin Khandelwal, et al.
Publicado: (2021)

Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine
por: Taweewun Hunsawong, et al.
Publicado: (2021)

Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
por: Ravi Kant, et al.
Publicado: (2021)

Investigation of the impact of SARS-CoV infection on the immunologic status and lung function after 15 years
por: Jia Li, et al.
Publicado: (2021)

Development and characterization of a quantitative ELISA to detect anti-SARS-CoV-2 spike antibodies
por: Magdalena M. Żak, et al.
Publicado: (2021)

Persistence of SARS-CoV-2-Specific Antibodies for 13 Months after Infection
por: Indrė Kučinskaitė-Kodzė, et al.
Publicado: (2021)

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity
por: Carolin Loos, et al.
Publicado: (2020)

Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patients
por: Olivier Bylicki, et al.
Publicado: (2021)

SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity
por: Michihito Sasaki, et al.
Publicado: (2021)

Persistence of the SARS-CoV-2 Antibody Response in Asymptomatic Patients in Correctional Facilities
por: Xiaodong Tian, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in the general population of Oman: results from four successive nationwide sero-epidemiological surveys
por: Seif Salem Al-Abri, et al.
Publicado: (2021)

La Saliva como Biomuestra para Diagnóstico de Infección por SARS-CoV-2: Una Revisión
por: Morales-Espinosa,Rolando
Publicado: (2020)

Weekly SARS-CoV-2 screening of asymptomatic kindergarten to grade 12 students and staff helps inform strategies for safer in-person learning
por: Shira Doron, et al.
Publicado: (2021)

COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany’s Largest Public Health Department (Cologne)
por: Lea Hsu, et al.
Publicado: (2021)

Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2
por: Espiridión Ramos-Martinez, et al.
Publicado: (2021)

Tear antibodies to SARS‐CoV‐2: implications for transmission
por: Kevin J Selva, et al.
Publicado: (2021)